KEROS THERAPEUTICS, INC.

Analyst Reco. Keros Therapeutics, Inc.

Equities

KROS

US4923271013

Real-time Estimate Cboe BZX Other stock markets 15:07:16 13/05/2024 BST			5-day change	1st Jan Change
54 ^USD	-0.49%		-9.87%	+36.59%

05-08	Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000	MT
05-08	Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wedbush Starts Keros Therapeutics at Outperform With $86 Price Target	31/07/23	MT
BofA Securities Initiates Keros Therapeutics With Buy Rating, $65 Price Target	26/07/23	MT
BofA Securities Starts Keros Therapeutics at Buy With $65 Price Target	26/07/23	MT
Piper Sandler Adjusts Keros Therapeutics' Price Target to $110 From $120, Keeps Overweight Rating	05/05/23	MT
Cowen Starts Keros Therapeutics at Outperform	14/02/23	MT
BTIG Adjusts Price Target on Keros Therapeutics to $105 From $95, Maintains Buy Rating	13/12/22	MT
Truist Securities Starts Keros Therapeutics at Buy With $100 Price Target	18/10/22	MT
BTIG Initiates Coverage on Keros Therapeutics With Buy Rating, $80 Price Target	26/07/22	MT
Piper Sandler Adjusts Keros Therapeutics' Price Target to $120 from $90, Keeps Overweight Rating	18/05/22	MT
KEROS THERAPEUTICS : Jefferies Adjusts Keros Therapeutics PT to $75 From $70, Maintains Buy Rating	24/06/21	MT
KEROS THERAPEUTICS : Piper Sandler Adjusts Keros Therapeutics' Price Target to $95 From $75, Reiterates Overweight Rating	08/12/20	MT
KEROS THERAPEUTICS : HC Wainwright Adjusts Keros Therapeutics' Price Target to $100 From $50, Keeps at Buy	08/12/20	MT
KEROS THERAPEUTICS : SVB Leerink Adjusts Keros Therapeutics' Price Target to $80 from $42, Keeps Outperform Rating	08/12/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer